Erythropoietin exerts anti-epileptic effects with the suppression of aberrant new cell formation in the dentate gyrus and upregulation of neuropeptide Y in seizure model of rats

Brain Research

Volumn 1296, Issue , 2009, Pages 127-136

  Kondo, Akihiko ^a   Shingo, Tetsuro ^a   Yasuhara, Takao ^a   Kuramoto, Satoshi ^a   Kameda, Masahiro ^a   Kikuchi, Yoichiro ^a   Matsui, Toshihiro ^a   Miyoshi, Yasuyuki ^a   Agari, Takashi ^a   Borlongan, Cesario V ^b   Date, Isao ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Apoptosis; Cell proliferation; Generalized seizure; Neuropeptide Y; Neuroprotection

Indexed keywords

ANTICONVULSIVE AGENT; ERYTHROPOIETIN; ERYTHROPOIETIN ANTIBODY; ERYTHROPOIETIN RECEPTOR; KAINIC ACID; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPROTECTIVE AGENT; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DENTATE GYRUS; DISEASE SEVERITY; EPILEPSY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; MORTALITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEIZURE; UPREGULATION;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; CA1 REGION, HIPPOCAMPAL; CELL PROLIFERATION; DENTATE GYRUS; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; HEMATOPOIESIS; KAINIC ACID; MALE; NEURONS; NEUROPEPTIDE Y; RATS; RATS, INBRED F344; RECEPTORS, NEUROPEPTIDE Y; SEIZURES; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; UP-REGULATION;

ANIMALIA; RATTUS;

EID: 70349299783     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.08.025     Document Type: Article

References (75)

1. Baraban S.C., Hollopeter G., Erickson J.C., Schwartzkroin P.A., and Palmiter R.D. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17 (1997) 8927-8936
2. Bartesaghi S., Marinovich M., Corsini E., Galli C.L., and Viviani B. Erythropoietin: a novel neuroprotective cytokine. Neurotoxicology 26 (2005) 923-928
3. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14 (1985) 375-403
4. Ben-Ari Y., Tremblay E., Ottersen O.P., and Meldrum B.S. The role of epileptic activity in hippocampal and "remote" cerebral lesions induced by kainic acid. Brain Res. 191 (1980) 79-97
5. Benmaamar R., Pham-Le B.T., Marescaux C., Pedrazzini T., and Depaulis A. Induced down-regulation of neuropeptide Y-Y1 receptors delays initiation of kindling. Eur. J. Neurosci. 18 (2003) 768-774
6. Brines M., and Cerami A. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J. Intern. Med. 264 (2008) 405-432
7. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., Itri L.M., and Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA 97 (2000) 10526-10531
8. Buemi M., Cavallaro E., Floccari F., Sturiale A., Aloisi C., Trimarchi M., Grasso G., Corica F., and Frisina N. Erythropoietin and the brain: from neurodevelopment to neuroprotection. Clin. Sci. (Lond.) 103 (2002) 275-282
9. Cerami A. Beyond erythropoiesis: novel applications for recombinant human erythropoietin. Semin. Hematol. 38 (2001) 33-39
10. Cerami A., Brines M.L., Ghezzi P., and Cerami C.J. Effects of epoetin alfa on the central nervous system. Semin. Oncol. 28 (2001) 66-70
11. Chu K., Jung K.H., Lee S.T., Kim J.H., Kang K.M., Kim H.K., Lim J.S., Park H.K., Kim M., Lee S.K., and Roh J.K. Erythropoietin reduces epileptogenic processes following status epilepticus. Epilepsia (2008)
12. Csete M., Rodriguez L., Wilcox M., and Chadalavada S. Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts. Neurosci. Lett. 359 (2004) 124-126
13. Dame C., Juul S.E., and Christensen R.D. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol. Neonate 79 (2001) 228-235
14. Ehrenreich H., Hasselblatt M., Dembowski C., Cepek L., Lewczuk P., Stiefel M., Rustenbeck H.H., Breiter N., Jacob S., Knerlich F., Bohn M., Poser W., Ruther E., Kochen M., Gefeller O., Gleiter C., Wessel T.C., De Ryck M., Itri L., Prange H., Cerami A., Brines M., and Siren A.L. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8 (2002) 495-505
15. Eid T., Brines M.L., Cerami A., Spencer D.D., Kim J.H., Schweitzer J.S., Ottersen O.P., and de Lanerolle N.C. Increased expression of erythropoietin receptor on blood vessels in the human epileptogenic hippocampus with sclerosis. J. Neuropathol. Exp. Neurol. 63 (2004) 73-83
16. El Bahh B., Cao J.Q., Beck-Sickinger A.G., and Colmers W.F. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246. Br. J. Pharmacol. 136 (2002) 502-509
17. El Bahh B., Balosso S., Hamilton T., Herzog H., Beck-Sickinger A.G., Sperk G., Gehlert D.R., Vezzani A., and Colmers W.F. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors. Eur. J. Neurosci. 22 (2005) 1417-1430
18. Engel Jr. J. Introduction to temporal lobe epilepsy. Epilepsy Res. 26 (1996) 141-150
19. Ferriero D.M. Protecting neurons. Epilepsia 46 Suppl 7 (2005) 45-51
20. Fujikawa D.G., Shinmei S.S., and Cai B. Kainic acid-induced seizures produce necrotic, not apoptotic, neurons with internucleosomal DNA cleavage: implications for programmed cell death mechanisms. Neuroscience 98 (2000) 41-53
21. Gayoso M.J., Primo C., al-Majdalawi A., Fernandez J.M., Garrosa M., and Iniguez C. Brain lesions and water-maze learning deficits after systemic administration of kainic acid to adult rats. Brain Res. 653 (1994) 92-100
22. Genc S., Koroglu T.F., and Genc K. Erythropoietin and the nervous system. Brain Res. 1000 (2004) 19-31
23. Gillardon F., Wickert H., and Zimmermann M. Up-regulation of bax and down-regulation of bcl-2 is associated with kainate-induced apoptosis in mouse brain. Neurosci. Lett. 192 (1995) 85-88
24. Hoffman G.E., Moore N., Fiskum G., and Murphy A.Z. Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp. Neurol. 182 (2003) 124-134
25. Howell O.W., Silva S., Scharfman H.E., Sosunov A.A., Zaben M., Shatya A., McKhann II G., Herzog H., Laskowski A., and Gray W.P. Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus. Neurobiol. Dis. 26 (2007) 174-188
26. Jakubs K., Nanobashvili A., Bonde S., Ekdahl C.T., Kokaia Z., Kokaia M., and Lindvall O. Environment matters: synaptic properties of neurons born in the epileptic adult brain develop to reduce excitability. Neuron 52 (2006) 1047-1059
27. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol. Rev. 72 (1992) 449-489
28. Jinde S., Masui A., Morinobu S., Noda A., and Kato N. Differential changes in messenger RNA expressions and binding sites of neuropeptide Y Y1, Y2 and Y5 receptors in the hippocampus of an epileptic mutant rat: Noda epileptic rat. Neuroscience 115 (2002) 1035-1045
29. Jung K.H., Chu K., Kim M., Jeong S.W., Song Y.M., Lee S.T., Kim J.Y., Lee S.K., and Roh J.K. Continuous cytosine-b-D-arabinofuranoside infusion reduces ectopic granule cells in adult rat hippocampus with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Eur. J. Neurosci. 19 (2004) 3219-3226
30. Kadota T., Shingo T., Yasuhara T., Tajiri N., Kondo A., Morimoto T., Yuan W.J., Wang F., Baba T., Tokunaga K., Miyoshi Y., and Date I. Continuous intraventricular infusion of erythropoietin exerts neuroprotective/rescue effects upon Parkinson's disease model of rats with enhanced neurogenesis. Brain Res. 1254 (2009) 120-127
31. Kalra S.P., and Kalra P.S. To subjugate NPY is to improve the quality of life and live longer. Peptides 28 (2007) 413-418
32. Kalviainen R. Monotherapy trial design: conversion versus de novo. Epilepsy Res. 45 (2001) 75-78 (discussion 79-80)
33. Kitano Y., Komiyama C., Makino M., Takasuna K., Satoh H., Aoki T., Kinoshita M., Takazawa A., Yamauchi T., and Sakurada S. Anticonvulsant and neuroprotective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats. Brain Res. 1057 (2005) 168-176
34. Klapstein G.J., and Colmers W.F. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J. Neurophysiol. 78 (1997) 1651-1661
35. Kondo T., Sharp F.R., Honkaniemi J., Mikawa S., Epstein C.J., and Chan P.H. DNA fragmentation and prolonged expression of c-fos, c-jun, and hsp70 in kainic acid-induced neuronal cell death in transgenic mice overexpressing human CuZn-superoxide dismutase. J. Cereb. Blood Flow Metab. 17 (1997) 241-256
36. Laskowski A., Howell O.W., Sosunov A.A., McKhann G., and Gray W.P. NPY mediates basal and seizure-induced proliferation in the subcallosal zone. NeuroReport 18 (2007) 1005-1008
37. Lothman E.W., and Collins R.C. Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res. 218 (1981) 299-318
38. Marchi N., Guiso G., Rizzi M., Pirker S., Novak K., Czech T., Baumgartner C., Janigro D., Caccia S., and Vezzani A. A pilot study on brain-to-plasma partition of 10, 11-dyhydro-10-hydroxy-5H-dibenzo(b, f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine. Epilepsia 46 (2005) 1613-1619
39. Mathern G.W., Pretorius J.K., Mendoza D., Lozada A., Leite J.P., Chimelli L., Fried I., Sakamoto A.C., Assirati J.A., and Adelson P.D. Increased hippocampal AMPA and NMDA receptor subunit immunoreactivity in temporal lobe epilepsy patients. J. Neuropathol. Exp. Neurol. 57 (1998) 615-634
40. Mennini T., De Paola M., Bigini P., Mastrotto C., Fumagalli E., Barbera S., Mengozzi M., Viviani B., Corsini E., Marinovich M., Torup L., Van Beek J., Leist M., Brines M., Cerami A., and Ghezzi P. Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo. Mol. Med. 12 (2006) 153-160
41. Mikati M.A., El Hokayem J.A., and El Sabban M.E. Effects of a single dose of erythropoietin on subsequent seizure susceptibility in rats exposed to acute hypoxia at P10. Epilepsia 48 (2007) 175-181
42. Morishita E., Masuda S., Nagao M., Yasuda Y., and Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76 (1997) 105-116
43. Morris M.J., Gannan E., Stroud L.M., Beck-Sickinger A.G., and O'Brien T.J. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors. Eur. J. Neurosci. 25 (2007) 1136-1143
44. Nadam J., Navarro F., Sanchez P., Moulin C., Georges B., Laglaine A., Pequignot J.M., Morales A., Ryvlin P., and Bezin L. Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus. Neurobiol. Dis. 25 (2007) 412-426
45. Nagai A., Nakagawa E., Choi H.B., Hatori K., Kobayashi S., and Kim S.U. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J. Neuropathol. Exp. Neurol. 60 (2001) 386-392
46. Nishimura T., Imai H., Minabe Y., Sawa A., and Kato N. Beneficial effects of FK506 for experimental temporal lobe epilepsy. Neurosci. Res. 56 (2006) 386-390
47. Parent J.M. The role of seizure-induced neurogenesis in epileptogenesis and brain repair. Epilepsy Res. 50 (2002) 179-189
48. In: Paxinos G., and Watson G. (Eds). The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, San Diego
49. Pollard H., Charriaut-Marlangue C., Cantagrel S., Represa A., Robain O., Moreau J., and Ben-Ari Y. Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience 63 (1994) 7-18
50. Poulsen F.R., Jahnsen H., Blaabjerg M., and Zimmer J. Pilocarpine-induced seizure-like activity with increased BNDF and neuropeptide Y expression in organotypic hippocampal slice cultures. Brain Res. 950 (2002) 103-118
51. Reibel S., Vivien-Roels B., Le B.T., Larmet Y., Carnahan J., Marescaux C., and Depaulis A. Overexpression of neuropeptide Y induced by brain-derived neurotrophic factor in the rat hippocampus is long lasting. Eur. J. Neurosci. 12 (2000) 595-605
52. Reibel S., Benmaamar R., Le B.T., Larmet Y., Kalra S.P., Marescaux C., and Depaulis A. Neuropeptide Y delays hippocampal kindling in the rat. Hippocampus 13 (2003) 557-560
53. Reynolds B.A., and Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255 (1992) 1707-1710
54. Richichi C., Lin E.J., Stefanin D., Colella D., Ravizza T., Grignaschi G., Veglianese P., Sperk G., During M.J., and Vezzani A. Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J. Neurosci. 24 (2004) 3051-3059
55. Rössler J., Stolze I., Frede S., Freitag P., Schweigerer L., Havers W., and Fandrey J. Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site. J. Cell. Biochem. 93 (2004) 153-161
56. Scharfman H.E., Goodman J.H., and Sollas A.L. Granule-like neurons at the hilar/CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis. J. Neurosci. 20 (2000) 6144-6158
57. Scharfman H.E., Goodman J.H., Sollas A.L., and Croll S.D. Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor. Exp. Neurol. 174 (2002) 201-214
58. Shapiro L.A., and Ribak C.E. Newly born dentate granule neurons after pilocarpine-induced epilepsy have hilar basal dendrites with immature synapses. Epilepsy Res. 69 (2006) 53-66
59. Shingo T., Sorokan S.T., Shimazaki T., and Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci. 21 (2001) 9733-9743
60. Silva A.P., Xapelli S., Pinheiro P.S., Ferreira R., Lourenco J., Cristovao A., Grouzmann E., Cavadas C., Oliveira C.R., and Malva J.O. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats. J. Neurochem. 93 (2005) 163-170
61. Spandou E., Papadopoulou Z., Soubasi V., Karkavelas G., Simeonidou C., Pazaiti A., and Guiba-Tziampiri O. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res. 1045 (2005) 22-30
62. Sperk G., Lassmann H., Baran H., Seitelberger F., and Hornykiewicz O. Kainic acid-induced seizures: dose-relationship of behavioural, neurochemical and histopathological changes. Brain Res. 338 (1985) 289-295
63. Sperk G., Hamilton T., and Colmers W.F. Neuropeptide Y in the dentate gyrus. Prog. Brain Res. 163 (2007) 285-297
64. Tasch E., Cendes F., Li L.M., Dubeau F., Andermann F., and Arnold D.L. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. Ann. Neurol. 45 (1999) 568-576
65. Tokuhara D., Sakuma S., Hattori H., Matsuoka O., and Yamano T. Kainic acid dose affects delayed cell death mechanism after status epilepticus. Brain Dev. 29 (2007) 2-8
66. Tu B., Jiao Y., Herzog H., and Nadler J.V. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: correlation with Y2 receptor plasticity. Neuroscience 143 (2006) 1085-1094
67. Uzüm G., Sarper Diler A., Bahçekapili N., and Ziya Ziylan Y. Erythropoietin prevents the increase in blood-brain barrier permeability during pentylentetrazol induced seizures. Life Sci. 78 (2006) 2571-2576
68. Vezzani A., and Sperk G. Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy?. Neuropeptides 38 (2004) 245-252
69. Vezzani A., Michalkiewicz M., Michalkiewicz T., Moneta D., Ravizza T., Richichi C., Aliprandi M., Mule F., Pirona L., Gobbi M., Schwarzer C., and Sperk G. Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience 110 (2002) 237-243
70. Wen X., Huang Y., and Wang J. Erythropoietin preconditioning on hippocampus neuronal apoptosis following status epilepticus induced by Li-pilocarpine in rats through anti-caspase-3 expression. Neurol. India 54 (2006) 58-63 (discussion 63)
71. Won Y.J., Yoo J.Y., Lee J.H., Hwang S.J., Kim D., and Hong H.N. Erythropoietin is neuroprotective on GABAergic neurons against kainic acid-excitotoxicity in the rat spinal cell cultures. Brain Res. 1154 (2007) 31-39
72. Xiong Y., Lu D., Qu C., Goussev A., Schallert T., Mahmood A., and Chopp M. Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice. J. Neurosurg. 109 (2008) 510-521
73. Yang J., Huang Y., Yu X., Sun H., Li Y., and Deng Y. Erythropoietin preconditioning suppresses neuronal death following status epilepticus in rats. Acta Neurobiol. Exp. (Wars) 67 (2007) 141-148
74. Yasuhara T., Shingo T., Kobayashi K., Takeuchi A., Yano A., Muraoka K., Matsui T., Miyoshi Y., Hamada H., and Date I. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur. J. Neurosci. 19 (2004) 1494-1504
75. Zhang F., Signore A.P., Zhou Z., Wang S., Cao G., and Chen J. Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms. J. Neurosci. Res. 83 (2006) 1241-1251